|
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
|
5R25CA221738-02
|
$409,851
|
|
DECAPRIO, JAMES
|
DANA-FARBER CANCER INST
|
|
Yale SPORE in Skin Cancer
|
2P50CA121974-11A1
|
$2,500,000
|
|
BOSENBERG, MARCUS
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
$2,495
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
$47,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
$20,355
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Washington Womens Interagency HIV/AIDS Study
|
3U01AI034994-24S1
|
$106,140
|
|
KASSAYE, SEBLE
|
GEORGETOWN UNIVERSITY
|
|
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
|
1T32CA217834-01A1
|
$241,750
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-05
|
$592,247
|
$29,612
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity
|
1R33CA217702-01A1
|
$364,966
|
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$8,750
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$2,224
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$300,195
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Utilizing MEK Inhibition to Sensitize Microsatellite Stable Colorectal Cancer to Immune Checkpoint Therapy
|
1R01CA229259-01
|
$247,340
|
|
LIEU, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-03S1
|
$50,000
|
$1,250
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
$17,500
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
$17,207
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-18
|
$292,379
|
$43,857
|
CARVER, BRETT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,788,723
|
$715,489
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Unmasking targetable dependencies in cancer with intrinsic or acquired resistance to anti-cancer therapies
|
5F99CA222728-02
|
$35,610
|
|
ANDERSON, GRACE
|
DUKE UNIVERSITY
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
$61,660
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S4
|
$50,000
|
$500
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S5
|
$30,973
|
$310
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
2P30CA177558-06
|
$2,152,710
|
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Hawaii Cancer Center CCSG
|
2P30CA071789-18
|
$1,913,800
|
|
HOLCOMBE, RANDALL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-04
|
$768,950
|
$38,448
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$272,402
|
$54,480
|
Fowler, Daniel
|
CCR (NCI)
|
|
Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivors
|
5F99CA222742-02
|
$31,397
|
|
WILLIAMS, ANNALYNN
|
UNIVERSITY OF ROCHESTER
|
|
Understanding Ikaros molecular functions for targeted therapies of pre-B ALL
|
1R01CA230618-01
|
$373,355
|
|
SCHJERVEN, HILDE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study
|
5U01CA164973-07
|
$3,418,975
|
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Understanding causal effects of a treatment on survival in observational studies with unmeasured confounding and an application to effect of PMRT on breast cancer patients
|
5R03CA208387-02
|
$88,836
|
|
YANG, FAN
|
UNIVERSITY OF COLORADO DENVER
|
|
UM LAPs- U10 Grant
|
5U10CA180801-04
|
$803,208
|
$40,160
|
ZALUPSKI, MARK
|
UNIVERSITY OF MICHIGAN
|
|
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
|
5U54CA221208-02
|
$670,069
|
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-04
|
$592,771
|
$14,819
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers
|
5U01DK108320-04
|
$190,000
|
|
FORSMARK, CHRISTOPHER
|
UNIVERSITY OF FLORIDA
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA217685-02
|
$1,813,624
|
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Tumor-intrinsic signaling pathways restrict anti-tumor immunity in hepatocellular carcinoma
|
1R37CA230636-01
|
$387,731
|
|
LUJAMBIO, AMAIA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$18,992
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$192,132
|
$76,853
|
Merino, Maria
|
CCR (NCI)
|
|
Translational Regulation by RNA Regulating Proteins in Leukemia
|
1K99CA229993-01
|
$140,859
|
|
VU, LY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Training program to promote diversity in cancer research
|
1R25CA229105-01
|
$125,517
|
|
WATABE, KOUNOSUKE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Training Program in Cancer Biology and Therapeutics
|
2T32CA071345-21A1
|
$394,619
|
|
HABER, DANIEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Training Program For Cancer Prevention and Control
|
1T32CA229114-01
|
$150,020
|
|
SHIELDS, PETER
|
OHIO STATE UNIVERSITY
|
|
Training in Translational Research of Lung, Head and Neck Cancer
|
2T32CA174648-06
|
$427,216
|
|
WANG, XIAO-JING
|
UNIVERSITY OF COLORADO DENVER
|
|
Tobacco Treatment in the Context of Lung Cancer Screening
|
5K07CA214839-02
|
$179,784
|
|
ROJEWSKI, ALANA
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Tissue Processing-Sequencing Facility
|
ZIC BC 011044
|
$651,382
|
$325,691
|
Vocke, Cathy
|
CCR (NCI)
|
|
The Zambia AIDS Malignancies Diagnosis and Pathogenesis Program (ZAMDAPP)
|
5U54CA221204-02
|
$673,579
|
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
|
5P50CA196516-02
|
$2,300,000
|
$2,300,000
|
BRUGAROLAS, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
The tumor suppressive role of PBRM1, the bromodomain-containing subunit of the PBAF chromatin remodeling complex
|
1U01CA207532-01A1
|
$349,399
|
$349,399
|
DYKHUIZEN, EMILY
|
PURDUE UNIVERSITY
|
|
The targeting of the HIF switch in kidney cancer
|
7R01CA181106-04
|
$404,838
|
$404,838
|
KOH, MEI YEE
|
UNIVERSITY OF UTAH
|
|
The Role of the miRNA Cluster at 14q32 in Lipid Regulation and Renal Cancer Biology
|
1R03CA212696-01A1
|
$74,750
|
$74,750
|
NANJUNDAN, MEERA
|
UNIVERSITY OF SOUTH FLORIDA
|
Total relevant funding to Kidney Cancer for this search: $46,805,874
|